The Food and Drug Administration granted priority review status to a new drug application filed by Auxilium Pharmaceuticals Inc. for Xiaflex, an experimental treatment for Dupuytren�s contracture. (AUXL) (Source: bizjournals.com Health Care:Industry Regulation headlines)
Read More... [Source: MedWorm: Dupuytren's Contracture - Posted by FreeAutoBlogger]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment